| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24208-507-01 | 24208-507 | HUMAN PRESCRIPTION DRUG | Lotemax SM | loteprednol etabonate | GEL | OPHTHALMIC | 20190225 | N/A | NDA | NDA208219 | Bausch & Lomb Incorporated | LOTEPREDNOL ETABONATE | 3.8 mg/g | 1 BOTTLE in 1 CARTON (24208-507-01) / .5 g in 1 BOTTLE |
| 24208-507-02 | 24208-507 | HUMAN PRESCRIPTION DRUG | Lotemax SM | loteprednol etabonate | GEL | OPHTHALMIC | 20190225 | N/A | NDA | NDA208219 | Bausch & Lomb Incorporated | LOTEPREDNOL ETABONATE | 3.8 mg/g | 1 BOTTLE in 1 CARTON (24208-507-02) / 5 g in 1 BOTTLE |
| 24208-507-07 | 24208-507 | HUMAN PRESCRIPTION DRUG | Lotemax SM | loteprednol etabonate | GEL | OPHTHALMIC | 20190225 | N/A | NDA | NDA208219 | Bausch & Lomb Incorporated | LOTEPREDNOL ETABONATE | 3.8 mg/g | 1 BOTTLE in 1 CARTON (24208-507-07) / 5 g in 1 BOTTLE |